Q2 revenue up 11%, half-year profit up 21%; Rs150 crore land purchase

Results RestatedExceptional ItemResults View source PDF Explain this filing

JLHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.7%Reaction day

₹243.05

prior close

₹248.65

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+3.3% vs market

Hospital peers, median of 27sector+1.4%+2.3% vs sector

On the reaction day the stock moved 3.3 pts more than Nifty Microcap 250 and 2.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.6

10m

-1.2

15m

-1.0

30m

-1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.7+0.4+3.3+1.4+2.3

Next day

+5.1+2.1+3.0+3.3+1.8

+6.1+2.2+3.9+3.2+2.9

+7.0+2.9+4.1+4.2+2.8

+7.8pendingpending+5.1+2.7

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board approved unaudited Q2 and half-year results for September 2026, with an unmodified review. Consolidated Q2 revenue rose 11.1% to Rs 456.50 crore and profit for owners was nearly flat at Rs 74.45 crore. Half-year revenue rose 11.9% to Rs 861.42 crore and profit rose 20.9% to Rs 177.19 crore. It also approved a healthcare subsidiary and a Rs 150 crore purchase of 11,452.07 square metres of Pune land.

Likely market impact

Growth was positive but modest. The Rs150 crore land payment could raise near-term cash and funding needs.